MD
Associate Professor, Hematology
Clinical Director of Cellular Therapy Program
Medical Director, Adult CAR-T
UNC-Chapel Hill
Cancer Therapeutics Research Program
Area of Interest
My primary research interest is in novel therapies for the treatment of lymphoma. My particular focus is in cellular therapy including innovative approaches to chimeric antigen receptor T-cell (CAR-T) therapy, improving the efficacy of CAR-T cells, and management and prevention of unique toxicities associated with this treatment. My ultimate goal is to improve therapeutic options of lymphoma patients, while minimizing toxicities and maintaining their quality of life.
Awards and Honors
- ASH Scholar Award, 2024
- Joanne Levy, MD, Memorial Award for Outstanding Achievement, 2024
- Oncology K12 Grant, 2018
- ASCO/AACR Methods in Clinical Cancer Research Workshop, 2017
- Cancer Outcomes Research Program Travel Award, UNC Lineberger Comprehensive Cancer Center, 2015
- Department of Medicine Research Grant, University of Virginia, 2012
- Crile Research Fellowship, Case Western Reserve University, 2008
News and Stories
Transformational $20 million commitment will support UNC Lineberger’s Cellular Immunotherapy Program
This gift will fuel the next generation of cancer treatments, supporting all aspects of the UNC Lineberger Cellular Immunotherapy Program with an emphasis on clinical trials, expansion of the cellular therapeutics facility, and faculty recruitment and retention.
UNC researchers presenting research advances at American Society of Hematology annual meeting
Nearly two dozen UNC faculty members and trainees will present research and participate in scientific symposia and educational sessions at the ASH Annual Meeting.
